SCHEMBL25412556

SCHEMBL25412556

CNC(=O)[C@H](Cc1cccc(Br)c1)NC(=O)c1cc(-c2ccccc2Br)n(Cc2ccccc2)n1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MALT1 Q9UDY8 1/20 0.48
▸ CTSB P07858 7/20 0.45
▸ CTSS P25774 7/20 0.45
▸ CTSK P43235 6/20 0.45
▸ CTSL P07711 6/20 0.45
▸ BRD4 O60885 1/20 0.41
▸ PYGL P06737 4/20 0.41
▸ KCNJ6 P48051 2/20 0.40
▸ KCNJ5 P48544 2/20 0.40
▸ KCNJ3 P48549 2/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ MMP1 P03956 1/20 0.38
▸ FCER2 P06734 1/20 0.38
▸ MME P08473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25412557 1.00 MALT1 (0.48) MALT1CTSBCTSSCTSKCTSL
SCHEMBL30288608 0.92 MALT1 (0.53) MALT1CTSBCTSSCTSKCTSL
SCHEMBL30288612 0.90 MALT1 (0.56) MALT1CTSBCTSSCTSKCTSL
SCHEMBL30288589 0.89 MALT1 (0.54) MALT1CTSBCTSSCTSKCTSL
SCHEMBL30288595 0.89 MALT1 (0.49) MALT1CTSBCTSSCTSKCTSL
SCHEMBL26307120 0.87 MALT1 (0.49) MALT1CTSBCTSSCTSKCTSL
SCHEMBL30288624 0.87 MALT1 (0.49) MALT1CTSBCTSSCTSKCTSL
SCHEMBL30288593 0.86 SLC16A3 (0.48) MALT1CTSBCTSSCTSKCTSL
SCHEMBL30288584 0.86 MALT1 (0.52) MALT1CTSBCTSSCTSKCTSL
SCHEMBL30288649 0.86 MALT1 (0.48) MALT1CTSBCTSSCTSKCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023165168-A1 APPLICATION OF PYRAZOLE DERIVATIVE AS β2 ADRENERGIC RECEPTOR ALLOSTERIC MODULATOR, ANTAGONIST AND AGONIST 常州大学 2023-09-07 — — WO disclosed
CN-115894373-A N-substituted benzylpyrazole derivatives as beta 2 Use of allosteric modulators, antagonists and agonists of the adrenergic receptor 常州大学 2023-04-04 — — CN disclosed
Send feedback